Test Predicts Cognitive Decline in Parkinson's Disease

(Medage today) – The kinetic measures of a cerebrospinal liquid biomarker test (LCR) predicted the predicted cognitive decline from Parkinson’s disease and distinguished it from progressive supranuclear paralysis (PSP), an analysis of the data of three cohorts has shown …